Jubilant Pharmova Limited

NSE: JUBLPHARMAHealthcare

Jubilant Pharmova Limited Share Price & Analysis

₹924.50+1.83%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹924.50+1.83%
Open
₹923.35
High
₹930.00
Low
₹901.20
Close
₹924.50
52W High
₹1185.00
52W Low
₹784.00
Volume
498K
Lot Size
1
Sector
Healthcare
Market Cap
₹15K Cr
Face Value
₹1
Mid CapNIFTY 500Nifty Smallcap 250

Price Chart

Candle
Range

Fundamentals

P/E
38.00
Sector P/E
54.70
P/B
2.34
EPS
₹25.08
ROE
6.53%
ROCE
8.99%
D/E Ratio
0.51
Div Yield
0.54%
Book Value
₹445.00

Strengths

  • Attractively valued vs sector (P/E 38x vs industry 54.7x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    1,899
    ₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    9,100
    ₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    4,857
    ₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    8,650
    ₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    1,385
    ₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    1,120
    ₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    1,840
    ₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    JUBLPHARMA · as of Mar 2026

    Promoters50.67%
    FII17.23%0.27pp
    DII7.05%0.06pp
    Public24.48%0.34pp
    Others0.56%
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters50.67%50.67%50.67%50.67%50.67%50.67%
    FII20.29%19.06%19.50%17.94%16.96%17.23%
    DII2.89%3.77%4.06%5.66%6.99%7.05%
    Public25.56%25.91%25.18%25.17%24.82%24.48%
    Others0.58%0.58%0.58%0.56%0.56%0.56%

    Corporate Events

    JUBLPHARMA : 10-Aug-2026 : The Company has informed the Exchange that a Board meeting to be held on August 07, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be he

    Results9 Aug 2026

    To consider and approve the financial results for the period ended Jun 30, 2026

    Results6 Aug 2026

    Dividend - Rs 5 Per Share

    Dividend23 Jul 2026

    Dividend - Rs 5 Per Share

    Dividend24 Jul 2025

    Dividend - Rs 5 Per Share

    Dividend1 Aug 2024

    Dividend - Rs 5 Per Share

    Dividend9 Aug 2023

    Latest News

    All news

    Jubilant Foodworks reports Q1 FY27 financial results

    *Jubilant Foodworks reports Q1 FY27 financial results.* The company posted revenue of **₹523 crore** and net profit of **₹33.2 crore**, showing **12% YoY growth** in same-store sales. Margins improved due to operational efficiencies and supply chain optimization. 📊 *STOCKS:* $JUBLFOOD | 🏢 *SECTOR:* FMCG | #HIGHIMPACT #Earnings

    NSE Filing13 Aug
    High Impact

    Jubilant Foodworks reports Q1 FY27 financial results

    *Jubilant Foodworks reports Q1 FY27 financial results.* The company has announced its financial performance for the quarter ended June 30, 2026. Results include key metrics such as revenue, profit, and operational updates. **Figures** will impact investor sentiment and near-term price action. 📊 *STOCKS:* $JUBLFOOD | 🏢 *SECTOR:* CapitalMarkets | #HIGHIMPACT #Earnings

    NSE Filing13 Aug
    High Impact

    Jubilant Pharmova receives GST show cause notice

    *Jubilant Pharmova receives GST show cause notice.* The company disclosed receipt of a show cause notice related to GST dues. While the exact amount is not specified, such notices may lead to financial liability or legal proceedings. This could impact near-term sentiment and stock performance. 📊 *STOCKS:* JUBLPHARMA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #GST

    NSE Filing5d ago
    Medium Impact

    Jubilant Pharmova announces general updates

    *Jubilant Pharmova announces general updates.* The company filed routine corporate updates with the NSE, without disclosing specific financials or strategic moves. Such filings typically include administrative or compliance-related information. No immediate business-changing events were indicated. 📊 *STOCKS:* $JUBLPHARMA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate

    NSE Filing28 Aug
    Low Impact

    Jubilant Foodworks to host Q1FY27 analyst call

    *Jubilant Foodworks to host Q1FY27 analyst and investor call.* The company will discuss financial results and business updates. Event aimed at enhancing transparency with institutional investors. No new financial data released yet. 📊 *STOCKS:* $JUBLFOOD | 🏢 *SECTOR:* Consumer | #LOWIMPACT #Earnings

    NSE Filing20 Aug
    Low Impact

    Jubilant Agri grants ESOP to employees

    *Jubilant Agri grants ESOP to employees* as per a recent corporate filing. The move aims to align key personnel with long-term performance goals. No financial impact is expected in the near term. 📊 *STOCKS:* $JUBLPHARM | 🏢 *SECTOR:* Consumer Products | #LOWIMPACT #ESOP

    NSE Filing11 Aug
    Low Impact

    Jubilant Agri announces 18th AGM details

    *Jubilant Agri announces 18th AGM details.* The company has published notice for its 18th Annual General Meeting as per regulatory requirements. No financial or operational updates were disclosed. The event is a routine compliance activity. 📊 *STOCKS:* $JUBLPHARM | 🏢 *SECTOR:* Consumer | #LOWIMPACT #AGM

    NSE Filing10 Aug
    Low Impact

    Jubilant Foodworks files routine regulatory update

    *Jubilant Foodworks files routine disclosure under SEBI regulations.* This is a standard compliance update as per Listing Obligations and Disclosure Requirements (LODR) 2015. No financial or operational developments reported. Such filings are periodic and do not indicate immediate market-moving changes. 📊 *STOCKS:* $JUBLFOOD | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Regulation

    NSE Filing5 Aug
    Low Impact

    Jubilant Agri informs NCLT meeting notice via newspaper publication

    *Jubilant Agri informs NCLT meeting notice via newspaper publication.* The company has published a notice for the Hon'ble NCLT-convened meeting of equity shareholders and unsecured creditors. This is a procedural compliance step under insolvency proceedings. No financial figures or immediate market-moving details were disclosed. 📊 *STOCKS:* $JUBILANT | 🏢 *SECTOR:* Consumer Products | #LOWIMPACT #NCLT

    NSE Filing4 Aug
    Low Impact

    Jubilant Ingrevia publishes mandatory newspaper notice.

    *Jubilant Ingrevia publishes mandatory newspaper notice.* This is a routine regulatory disclosure as per corporate filing norms. No **financial** or **operational** impact is indicated. Such publications are standard practice for listed companies. 📊 *STOCKS:* $JUBLINGREAL | 🏢 *SECTOR:* Food Processing | #LOWIMPACT #CorporateFiling

    NSE Filing30 Jul
    Low Impact

    Financials

    Quarterly Results

    MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    Revenue
    ₹2.3K Cr
    7.9%
    ₹2.1K Cr
    7.9%
    ₹2.0K Cr
    3.4%
    ₹1.9K Cr
    1.5%
    ₹1.9K Cr
    5.9%
    ₹1.8K Cr
    4.0%
    ₹1.8K Cr
    1.2%
    ₹1.7K Cr
    Op. Profit
    ₹339 Cr
    17.3%
    ₹289 Cr
    15.2%
    ₹341 Cr
    17.6%
    ₹290 Cr
    15.9%
    ₹345 Cr
    20.2%
    ₹287 Cr
    0.7%
    ₹289 Cr
    14.7%
    ₹252 Cr
    OPM
    15.0%
    7.1%
    14.0%
    17.6%
    17.0%
    13.3%
    15.0%
    16.7%
    18.0%
    12.5%
    16.0%
    5.9%
    17.0%
    13.3%
    15.0%
    Net Profit
    ₹119 Cr
    112.5%
    ₹56 Cr
    53.3%
    ₹120 Cr
    17.6%
    ₹102 Cr
    32.5%
    ₹151 Cr
    49.5%
    ₹101 Cr
    1.0%
    ₹102 Cr
    78.8%
    ₹482 Cr
    EPS (₹)
    7.5
    113.7%
    3.51
    53.5%
    7.55
    16.9%
    6.46
    33.0%
    9.64
    52.3%
    6.33
    1.9%
    6.45
    78.7%
    30.26

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹8.3K Cr
    14.5%
    ₹7.2K Cr
    7.9%
    ₹6.7K Cr
    6.7%
    ₹6.3K Cr
    2.5%
    ₹6.1K Cr
    0.5%
    ₹6.1K Cr
    2.1%
    ₹6.0K Cr
    34.4%
    ₹9.1K Cr
    21.2%
    ₹7.5K Cr
    28.3%
    ₹5.9K Cr
    Expenses
    ₹7.0K Cr
    15.8%
    ₹6.1K Cr
    4.5%
    ₹5.8K Cr
    5.4%
    ₹5.5K Cr
    10.5%
    ₹5.0K Cr
    6.1%
    ₹4.7K Cr
    6.0%
    ₹4.4K Cr
    39.9%
    ₹7.4K Cr
    22.9%
    ₹6.0K Cr
    32.9%
    ₹4.5K Cr
    Op. Profit
    ₹1.3K Cr
    7.4%
    ₹1.2K Cr
    30.2%
    ₹901 Cr
    15.7%
    ₹779 Cr
    32.3%
    ₹1.1K Cr
    18.0%
    ₹1.4K Cr
    9.4%
    ₹1.5K Cr
    11.2%
    ₹1.7K Cr
    14.6%
    ₹1.5K Cr
    12.6%
    ₹1.4K Cr
    OPM
    15.0%
    6.3%
    16.0%
    23.1%
    13.0%
    8.3%
    12.0%
    36.8%
    19.0%
    17.4%
    23.0%
    11.5%
    26.0%
    36.8%
    19.0%
    5.0%
    20.0%
    13.0%
    23.0%
    Other Income
    ₹7 Cr
    98.3%
    ₹416 Cr
    647.4%
    ₹-76 Cr
    744.4%
    ₹-9 Cr
    212.5%
    ₹8 Cr
    97.0%
    ₹263 Cr
    16.9%
    ₹225 Cr
    190.4%
    ₹-249 Cr
    791.7%
    ₹36 Cr
    89.5%
    ₹19 Cr
    Interest
    ₹212 Cr
    11.7%
    ₹240 Cr
    11.8%
    ₹272 Cr
    44.7%
    ₹188 Cr
    29.7%
    ₹145 Cr
    21.2%
    ₹184 Cr
    8.0%
    ₹200 Cr
    9.1%
    ₹220 Cr
    22.5%
    ₹284 Cr
    16.7%
    ₹341 Cr
    Depreciation
    ₹440 Cr
    19.2%
    ₹369 Cr
    3.4%
    ₹382 Cr
    31.0%
    ₹554 Cr
    45.0%
    ₹382 Cr
    9.5%
    ₹349 Cr
    2.6%
    ₹340 Cr
    8.4%
    ₹371 Cr
    10.6%
    ₹415 Cr
    42.6%
    ₹291 Cr
    PBT
    ₹614 Cr
    37.4%
    ₹981 Cr
    477.1%
    ₹170 Cr
    507.1%
    ₹28 Cr
    95.6%
    ₹630 Cr
    44.4%
    ₹1.1K Cr
    8.1%
    ₹1.2K Cr
    36.4%
    ₹904 Cr
    5.2%
    ₹859 Cr
    16.4%
    ₹738 Cr
    Tax %
    35.0%
    133.3%
    15.0%
    73.7%
    57.0%
    82.9%
    333.0%
    879.4%
    34.0%
    30.8%
    26.0%
    3.7%
    27.0%
    25.0%
    36.0%
    38.5%
    26.0%
    18.2%
    22.0%
    Net Profit
    ₹398 Cr
    52.4%
    ₹836 Cr
    1045.2%
    ₹73 Cr
    212.3%
    ₹-65 Cr
    115.7%
    ₹413 Cr
    50.6%
    ₹836 Cr
    6.9%
    ₹898 Cr
    55.6%
    ₹577 Cr
    9.0%
    ₹634 Cr
    10.3%
    ₹575 Cr
    EPS (₹)
    25.02
    52.5%
    52.69
    988.6%
    4.84
    226.4%
    -3.83
    114.7%
    25.98
    50.5%
    52.47
    7.0%
    56.39
    56.4%
    36.06
    10.6%
    40.35
    11.6%
    36.14
    Div Payout
    20.0%
    122.2%
    9.0%
    91.2%
    102.0%
    178.5%
    -130.0%
    784.2%
    19.0%
    90.0%
    10.0%
    11.1%
    9.0%
    25.0%
    12.0%
    71.4%
    7.0%
    12.5%
    8.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    Reserves
    ₹7.1K Cr
    13.4%
    ₹6.2K Cr
    15.2%
    ₹5.4K Cr
    0.7%
    ₹5.4K Cr
    1.5%
    ₹5.3K Cr
    12.2%
    ₹4.7K Cr
    15.4%
    ₹5.6K Cr
    16.6%
    ₹4.8K Cr
    17.7%
    ₹4.1K Cr
    19.0%
    ₹3.4K Cr
    Borrowings
    ₹3.6K Cr
    32.4%
    ₹2.7K Cr
    25.5%
    ₹3.7K Cr
    0.4%
    ₹3.7K Cr
    15.2%
    ₹3.2K Cr
    12.8%
    ₹2.8K Cr
    41.1%
    ₹4.8K Cr
    0.7%
    ₹4.8K Cr
    39.5%
    ₹3.5K Cr
    14.2%
    ₹4.0K Cr
    Other Liabilities
    ₹4.6K Cr
    26.8%
    ₹3.6K Cr
    60.6%
    ₹2.2K Cr
    20.9%
    ₹1.9K Cr
    40.5%
    ₹1.3K Cr
    10.7%
    ₹1.2K Cr
    37.2%
    ₹1.9K Cr
    13.7%
    ₹1.7K Cr
    12.2%
    ₹1.9K Cr
    34.2%
    ₹1.4K Cr
    Total Liabilities
    ₹15.3K Cr
    21.4%
    ₹12.6K Cr
    11.0%
    ₹11.3K Cr
    3.7%
    ₹10.9K Cr
    11.2%
    ₹9.8K Cr
    12.2%
    ₹8.8K Cr
    28.8%
    ₹12.3K Cr
    8.8%
    ₹11.3K Cr
    19.7%
    ₹9.5K Cr
    6.3%
    ₹8.9K Cr
    Assets
    Fixed Assets
    ₹7.0K Cr
    34.6%
    ₹5.2K Cr
    1.7%
    ₹5.1K Cr
    1.8%
    ₹5.2K Cr
    6.4%
    ₹4.9K Cr
    5.7%
    ₹4.6K Cr
    27.3%
    ₹6.3K Cr
    12.3%
    ₹5.6K Cr
    4.6%
    ₹5.4K Cr
    5.8%
    ₹5.1K Cr
    CWIP
    ₹4.0K Cr
    11.3%
    ₹3.6K Cr
    72.6%
    ₹2.1K Cr
    34.6%
    ₹1.6K Cr
    43.3%
    ₹1.1K Cr
    21.5%
    ₹897 Cr
    16.8%
    ₹768 Cr
    14.8%
    ₹901 Cr
    34.3%
    ₹671 Cr
    1.9%
    ₹684 Cr
    Investments
    ₹61 Cr
    38.6%
    ₹44 Cr
    4.8%
    ₹42 Cr
    83.6%
    ₹256 Cr
    7.1%
    ₹239 Cr
    0.8%
    ₹241 Cr
    249.3%
    ₹69 Cr
    40.0%
    ₹115 Cr
    7.3%
    ₹124 Cr
    20.4%
    ₹103 Cr
    Other Assets
    ₹4.2K Cr
    12.6%
    ₹3.7K Cr
    8.9%
    ₹4.1K Cr
    4.4%
    ₹3.9K Cr
    8.2%
    ₹3.6K Cr
    20.4%
    ₹3.0K Cr
    41.2%
    ₹5.1K Cr
    10.3%
    ₹4.7K Cr
    42.7%
    ₹3.3K Cr
    8.5%
    ₹3.0K Cr
    Total Assets
    ₹15.3K Cr
    21.4%
    ₹12.6K Cr
    11.0%
    ₹11.3K Cr
    3.7%
    ₹10.9K Cr
    11.2%
    ₹9.8K Cr
    12.2%
    ₹8.8K Cr
    28.8%
    ₹12.3K Cr
    8.8%
    ₹11.3K Cr
    19.7%
    ₹9.5K Cr
    6.3%
    ₹8.9K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Operating CF
    ₹1.2K Cr
    14.5%
    ₹1.1K Cr
    10.4%
    ₹971 Cr
    46.9%
    ₹661 Cr
    21.1%
    ₹838 Cr
    53.0%
    ₹1.8K Cr
    15.6%
    ₹1.5K Cr
    37.5%
    ₹1.1K Cr
    13.9%
    ₹1.3K Cr
    2.8%
    ₹1.3K Cr
    Investing CF
    ₹-1.1K Cr
    323.2%
    ₹512 Cr
    185.9%
    ₹-596 Cr
    25.7%
    ₹-474 Cr
    46.7%
    ₹-323 Cr
    55.6%
    ₹-727 Cr
    172.3%
    ₹-267 Cr
    73.8%
    ₹-1.0K Cr
    65.8%
    ₹-614 Cr
    32.0%
    ₹-465 Cr
    Financing CF
    ₹95 Cr
    106.5%
    ₹-1.5K Cr
    236.3%
    ₹-432 Cr
    175.2%
    ₹-157 Cr
    375.8%
    ₹-33 Cr
    98.1%
    ₹-1.7K Cr
    62.8%
    ₹-1.1K Cr
    259.8%
    ₹657 Cr
    172.9%
    ₹-901 Cr
    31.3%
    ₹-686 Cr
    Net Cash Flow
    ₹179 Cr
    35.6%
    ₹132 Cr
    327.6%
    ₹-58 Cr
    293.3%
    ₹30 Cr
    93.8%
    ₹482 Cr
    173.9%
    ₹-652 Cr
    389.8%
    ₹225 Cr
    70.4%
    ₹761 Cr
    459.0%
    ₹-212 Cr
    281.2%
    ₹117 Cr
    Free Cash Flow
    ₹-120 Cr
    215.8%
    ₹-38 Cr
    145.8%
    ₹83 Cr
    161.5%
    ₹-135 Cr
    156.0%
    ₹241 Cr
    81.0%
    ₹1.3K Cr
    30.3%
    ₹975 Cr
    106.1%
    ₹473 Cr
    42.2%
    ₹819 Cr
    1.6%
    ₹806 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Debtor Days
    47d
    4.4%
    45d
    10.0%
    50d
    10.7%
    56d
    1.8%
    55d
    12.2%
    49d
    38.0%
    79d
    54.9%
    51d
    7.3%
    55d
    12.7%
    63d
    Inventory Days
    170d
    4.5%
    178d
    19.1%
    220d
    17.9%
    268d
    13.0%
    308d
    14.9%
    268d
    42.1%
    463d
    215.0%
    147d
    16.9%
    177d
    20.6%
    223d
    Days Payable
    170d
    7.6%
    158d
    8.2%
    146d
    8.8%
    160d
    15.1%
    139d
    12.1%
    124d
    54.6%
    273d
    157.5%
    106d
    26.9%
    145d
    5.8%
    137d
    Cash Conv. Cycle
    47d
    27.7%
    65d
    47.6%
    124d
    24.8%
    165d
    26.3%
    224d
    15.5%
    194d
    27.6%
    268d
    191.3%
    92d
    5.7%
    87d
    41.6%
    149d
    Working Capital Days
    13d
    18.8%
    16d
    71.4%
    56d
    1.8%
    57d
    1.8%
    56d
    24.3%
    74d
    19.4%
    62d
    37.8%
    45d
    0.0%
    45d
    10.0%
    50d
    ROCE
    9.0%
    10.0%
    10.0%
    42.9%
    7.0%
    133.3%
    3.0%
    70.0%
    10.0%
    16.7%
    12.0%
    20.0%
    15.0%
    6.3%
    16.0%
    6.7%
    15.0%
    0.0%
    15.0%

    Source: Screener.in · Lower days = better efficiency

    About Jubilant Pharmova Limited

    Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]

    HealthcarePharmaceuticals & Biotechnology

    Frequently Asked Questions

    What is Jubilant Pharmova Limited share price today?
    Jubilant Pharmova Limited (JUBLPHARMA) is currently trading at ₹924.5 on NSE, up 1.83% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Jubilant Pharmova Limited available in F&O (Futures & Options)?
    Yes, Jubilant Pharmova Limited (JUBLPHARMA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Jubilant Pharmova Limited 52-week high and low?
    Jubilant Pharmova Limited's 52-week high is ₹1,185 and the 52-week low is ₹784. The current price of ₹924.5 is 22.0% below the 52W high.
    What is Jubilant Pharmova Limited P/E ratio?
    Jubilant Pharmova Limited's current P/E ratio is 38. This indicates the market is paying ₹38 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Jubilant Pharmova Limited options?
    Jubilant Pharmova Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade JUBLPHARMA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.